Schedule 13G ownership disclosure

Hancock Jaffe Laboratories, Inc.

Security class unavailable · CUSIP: 41015N106

Event date: 2018-12-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
503,500
Percent of class
4.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-074595
Form type
SC 13G/A
Filer
ACT CAPITAL MANAGEMENT, LLC
CIK
CIK 1442273
Filed
Dec 26, 2018
Reporting period
Dec 19, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub